Evidence map›Paper›PMID 42253166›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2026

Dual Functionality of a Plasmonic Gold Photocatalyst in the Reversible Dehydrogenation / Hydrogenation of N-Heterocycles.

Alba Sorroche, Alberto Casu, Andrea Falqui, José María López-de-Luzuriaga, Miguel Monge

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alba SorrocheDepartamento De Química, Instituto De Investigación en Química de La Universidad de La Rioja (IQUR), Universidad De La Rioja, Complejo Científico-Tecnológico, Logroño, Spain.
Alberto CasuDepartment of Physics "Aldo Pontremoli", Interdisciplinary Centre for Nanostructured Materials and Interfaces (CIMaINa), University of Milan, Milan, Italy.
Andrea FalquiDepartment of Physics "Aldo Pontremoli", Interdisciplinary Centre for Nanostructured Materials and Interfaces (CIMaINa), University of Milan, Milan, Italy.
José María López-de-LuzuriagaDepartamento De Química, Instituto De Investigación en Química de La Universidad de La Rioja (IQUR), Universidad De La Rioja, Complejo Científico-Tecnológico, Logroño, Spain.
Miguel MongeDepartamento De Química, Instituto De Investigación en Química de La Universidad de La Rioja (IQUR), Universidad De La Rioja, Complejo Científico-Tecnológico, Logroño, Spain.

Funding

DGI MICINN/FEDER PID2022-139739NB-l00Fondazione Romeo ed Enrica Invernizzi
6 · The paper itself

Abstract

LOHC (Liquid Organic Hydrogen Carrier) systems have emerged as a promising strategy for hydrogen storage and distribution. Among these, N-Heterocycles stand out due to their high hydrogen capacity. Their photocatalytic dehydrogenation has attracted significant attention due to the environmentally friendly conditions under which the reaction can proceed. We report here a new hybrid plasmonic material in which a covalent organic framework (COF) serves as a stabilizing matrix for gold nanoparticles, grafted in situ via an organometallic approach, with sizes ranging from 2 to 4 nm. We have employed the synthesized material as a recyclable photocatalyst in a light-mediated dehydrogenation of N-Heterocycles. This new carbon-based semiconductor photocatalyst also introduces a novel photocatalyst capable of generating both dehydrogenation and hydrogenation products by simply changing the reaction conditions, offering a significant advance for hydrogen storage.

Indexed as

catalysisCOFgold nanoparticleshydrogen storageN‐heterocycles

Identifiers

PMID42253166
PMCPMC13360652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.